Latest news
Loading news…
Glycominds
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Lod, HaMerkaz, Israel Founded 1999 11-50 employees For Profit
Glycominds develops and commercializes autoimmune and chronic inflammatory disease management tools focused on multiple sclerosis.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
1
Patents
6
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 24
- Active products
- 9
- Patents granted
- 6
- Trademarks
- 0
- Top patent class
- Testing
- IT spend
- $9M
Company Info
- Founded
- 1999
- Employees
- 11-50
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- HQ
- Lod, HaMerkaz, Israel
- Region
- Europe, Middle East, and Africa (EMEA), Middle East, Middle East and North Africa (MENA)
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- -0.3
- Trend (30d)
- -0.7
- Trend (90d)
- -0.4
1
professional contacts at Glycominds
Contact execs at Glycominds →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Glycominds
Loading news…
FAQs about Glycominds
People who checked this page also checked these
Browse the full Acquirezy directory.